Generate Biomedicines, Inc.
NASDAQGenerate Biomedicines has rarely been noisier. The stock is up 17% on the week, short sellers are piling in at the fastest pace since listing, and Nvidia just revealed a fresh stake — all at the same time. The short interest story is the most eye-catching tension. Shorts have rebuilt aggressively: estimated shares short jumped 58% in a single week to 3.16 million, and the…
GENB short interest
Full pulse commentary is for ORTEX subscribers. The live data picture for GENB below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for GENB are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 16 May 2026
Generate Biomedicines has rarely been noisier. The stock is up 17% on the week, short sellers are piling in at the fastest pace since listing, and Nvidia just revealed a fresh stake — all at the same time. The short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GENB — free to start on ORTEX.
Sign up for free →Open GENB on ORTEX